Health

Nanobiotix

Nanobiotix is a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer
Industry
MedTech
Year invested
2005
Status
Dual IPO on Euronext (NANO) & Nasdaq (NBTX)
Active
Other investors
Bpifrance, CM-CIC, Seventure
Location
France, US